Evidence map›Paper›PMID 39358462›Full record

ArticleScientific reports2024

The role of TiO

Xiaoyu Cong, Paweł Mazierski, Magdalena Miodyńska, Adriana Zaleska-Medynska, Harald Horn, Thomas Schwartz, Marta Gmurek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoyu CongInstitute of Functional Interfaces (IFG), Microbiology/Molecular Biology Department, Karlsruhe Institute of Technology (KIT), Hermann von Helmholtz Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Paweł MazierskiDepartment of Environmental Technology, Faculty of Chemistry, University of Gdansk, Gdansk, 80-308, Poland.
Magdalena MiodyńskaDepartment of Environmental Technology, Faculty of Chemistry, University of Gdansk, Gdansk, 80-308, Poland.
Adriana Zaleska-MedynskaDepartment of Environmental Technology, Faculty of Chemistry, University of Gdansk, Gdansk, 80-308, Poland.
Harald HornWater Chemistry and Water Technology, Karlsruhe Institute of Technology, Engler-Bunte-Institut, 76131, Karlsruhe, Germany.
Thomas SchwartzInstitute of Functional Interfaces (IFG), Microbiology/Molecular Biology Department, Karlsruhe Institute of Technology (KIT), Hermann von Helmholtz Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Marta GmurekInstitute of Functional Interfaces (IFG), Microbiology/Molecular Biology Department, Karlsruhe Institute of Technology (KIT), Hermann von Helmholtz Platz 1, 76344, Eggenstein-Leopoldshafen, Germany. marta.gmurek@p.lodz.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics are extensively used in human medicine, aquaculture, and animal husbandry, leading to the release of antimicrobial resistance into the environment. This contributes to the rapid spread of antibiotic-resistant genes (ARGs), posing a significant threat to human health and aquatic ecosystems. Conventional wastewater treatment methods often fail to eliminate ARGs, prompting the adoption of advanced oxidation processes (AOPs) to address this growing risk. The study investigates the efficacy of visible light-driven photocatalytic systems utilizing two catalyst types (TiO

Indexed as

TitaniumAnti-Bacterial AgentsCatalysisCopperDrug Resistance, BacterialDrug Resistance, MicrobialGenes, BacterialGraphiteLightNitrilesNitrogen CompoundsOxidation-ReductionOzoneWastewaterWater PurificationAnti-Bacterial AgentsCopperGraphitegraphitic carbon nitrideNitrilesNitrogen CompoundsOzoneTitaniumtitanium dioxideWastewaterAntibiotic-resistant bacteriaAntibiotic-resistant genesBimetallic catalystsPhotocatalyst-assisted peroxone processPhotocatalytic ozonationRegrowth

Identifiers

PMID39358462
PMCPMC11447026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.